Home
>
National Drug Code (NDC)
>
Divalproex Sodium
Divalproex Sodium - 51079-474-20 - (divalproex sodium)
Drug Information of Divalproex Sodium
| Product NDC: | 51079-474 |
| Proprietary Name: | Divalproex Sodium |
| Non Proprietary Name: | divalproex sodium |
| Active Ingredient(s): | 250 mg/1 & nbsp; divalproex sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Divalproex Sodium
| Product NDC: | 51079-474 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090062 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121011 |
Package Information of Divalproex Sodium
| Package NDC: | 51079-474-20 |
| Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-474-20) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (51079-474-01) |
NDC Information of Divalproex Sodium
| NDC Code | 51079-474-20 |
| Proprietary Name | Divalproex Sodium |
| Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-474-20) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (51079-474-01) |
| Product NDC | 51079-474 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | divalproex sodium |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20121011 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | DIVALPROEX SODIUM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
